0001213900-24-107606.txt : 20241210 0001213900-24-107606.hdr.sgml : 20241210 20241210215608 ACCESSION NUMBER: 0001213900-24-107606 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241206 FILED AS OF DATE: 20241210 DATE AS OF CHANGE: 20241210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Song Paul Y. CENTRAL INDEX KEY: 0001991119 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40427 FILM NUMBER: 241539979 MAIL ADDRESS: STREET 1: NKGEN BIOTECH, INC. STREET 2: 3001 DAIMLER STREET CITY: SANTA ANA STATE: CA ZIP: 92705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NKGen Biotech, Inc. CENTRAL INDEX KEY: 0001845459 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3001 DAIMLER ST, CITY: SANTA ANA STATE: CA ZIP: 92705 BUSINESS PHONE: (949) 396-6830 MAIL ADDRESS: STREET 1: 3001 DAIMLER ST, CITY: SANTA ANA STATE: CA ZIP: 92705 FORMER COMPANY: FORMER CONFORMED NAME: Graf Acquisition Corp. IV DATE OF NAME CHANGE: 20210210 4 1 ownership.xml X0508 4 2024-12-06 0 0001845459 NKGen Biotech, Inc. NKGN 0001991119 Song Paul Y. NKGEN BIOTECH, INC. 3001 DAIMLER STREET SANTA ANA CA 92705 0 1 0 0 Chief Executive Officer 0 Stock Option (right to buy) 0.438 2024-12-06 4 A 0 2000000 0.00 A 2034-12-06 Common Stock 2000000 2000000 D On December 6, 2024, the Reporting Person was granted 2,000,000 options pursuant to the Company's 2023 Equity Incentive Plan, vesting in 48 equal installments on the sixth of each month, beginning January 6, 2025, and ending December 6, 2028, subject to the Reporting Person's continued service with the Issuer on each respective vesting date. /s/ Paul Y. Song 2024-12-10